Dr. Jose David Sandoval-Sus, MD

Dr. Sandoval-Sus practices at Memorial Hospital West in Pembroke Pines, Florida, part of Memorial Healthcare System.

Dr. Sandoval-Sus' NPI, 1174846158, was assigned on March 5, 2010. Dr. Sandoval-Sus holds Florida license ME116179.

Dr. Sandoval-Sus' primary practice is Memorial Hospital West, at 703 N Flamingo Rd, Pembroke Pines, FL 33028 in Broward County. The practice phone is (954) 436-5000.

Dr. Sandoval-Sus' primary practice is Memorial Hospital West in Pembroke Pines, Florida, part of Memorial Healthcare System. Dr. Sandoval-Sus is also affiliated with Memorial Hospital Pembroke. The medical group on file is Memorial Division of High Risk Obstetrics. Dmand AI also links Dr. Sandoval-Sus to 2 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sandoval-Sus practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sandoval-Sus' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sandoval-Sus is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sandoval-Sus' licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Sandoval-Sus treats.

CMS data shows 427 Medicare services from Dr. Sandoval-Sus across 8 procedure codes in 2024, for 167 Medicare patients. Medicare paid $33,674 for them.

CMS counts 167 Medicare patients who saw Dr. Sandoval-Sus in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sandoval-Sus' median patient age at 68, with 47% women.

In 2024, Dr. Sandoval-Sus wrote 635 Medicare Part D claims for 101 patients. 59% of them were for generic drugs. CMS names the drug for 492 of them, across 18 drugs with 11 or more claims each, at $4,175,651 in total drug cost. In 2023, CMS named 368 claims across 12 drugs.

Dr. Sandoval-Sus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sandoval-Sus as offering telehealth.

Dmand AI links 28 papers to Dr. Sandoval-Sus, published from 2014 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Lymphoma, Mantle-Cell, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Sandoval-Sus has published most often in Clin Lymphoma Myeloma Leuk. Dr. Sandoval-Sus' most frequent co-authors are Julio C. Chavez, MD, Lubomir Sokol, MD and Bijal D. Shah, MD.

CMS Open Payments shows 180 general payments to Dr. Sandoval-Sus from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Seagen Inc. paid the most, $53,801. It also lists 18 research payments totaling $177,792 in 2025.

Dr. Sandoval-Sus is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.